Table 2.
Responses of participating physicians (n = 151) regarding CVS supportive measures in the management of AlP-intoxicated patients.
| Questions addressing CVS supportive measures in AlP-intoxicated patients | Frequency (n = 151) | % |
|---|---|---|
| Q In your practice, fluid therapy for the management of acute AlP poisoning is:a | ||
| Initiated Empirically IV Crystalloids | 86 | 57.0 |
| Guided with CVP measurement | 65 | 43.0 |
| Guided with ECHO to assess ejection fraction and myocardial contractility | 59 | 39.1 |
| Q In your practice, management of AlP-induced refractory hypotension include:a | ||
| Noradrenaline | 137 | 90.7 |
| Dobutamine and/or dopamine | 69 | 45.7 |
| IV Hydrocortisone | 38 | 25.2 |
| Aggressive CVS supportive measures such as IABP/ECMO | 22 | 14.6 |
| Q When you administer noradrenaline infusion in AlP cases the dose regimen is:a | ||
| No fixed regimen for noradrenaline infusion in these cases. | 55 | 36.4 |
| Start with rate of infusion 5 ml/h of single dose. | 44 | 29.1 |
| Start with rate of infusion 7.4 ml/h of single dose. | 8 | 5.3 |
| Dose readjusted every 30 min or 1 h according to perfusion status. | 71 | 47.0 |
| Maximum rate of infusion (≥30 ml/h single dose) could be applied in severe cases. | 38 | 25.2 |
ECHO, echocardiogram.
aMultiple response question, percent is calculated out of total (n = 151) per each answer.